Alpha 2.0
Login Register
» Articles » PMID: 29059113

The Diagnostic Utility of Synovial Fluid Markers in Periprosthetic Joint Infection: A Systematic Review and Meta-analysis

Overview
Journal J Am Acad Orthop Surg
Publisher Wolters Kluwer
Specialties General Surgery
Orthopedics
Date 2017 Oct 24
PMID 29059113
Citations 20
Authors
Anas Saleh
Deepak Ramanathan
Marcelo Bogliolo P Siqueira
Alison K Klika
Wael K Barsoum
Carlos A Higuera Rueda
Affiliations
Soon will be listed here.
Abstract

Introduction: This study is a systematic review of all reported synovial fluid markers for the diagnosis of periprosthetic joint infection and a meta-analysis of the most frequently reported markers to identify those of greatest diagnostic utility.

Methods: A search of six databases was conducted to identify all studies evaluating the utility of synovial fluid markers in the diagnosis of periprosthetic joint infection. Two observers assessed methodologic quality and extracted data independently. A meta-analysis of the most frequently reported markers was performed.

Results: Twenty-three studies were included in the meta-analysis. The most common markers (and their respective area under the curve) were interleukin-17 (0.974), leukocyte esterase (0.968), α-defensin (0.958), interleukin-6 (0.956), interleukin-1β (0.948), and C-reactive protein (0.927). Among these markers, α-defensin had the highest diagnostic odds ratio but did not achieve statistically significant superiority.

Conclusion: The most frequently studied synovial fluid markers for the diagnosis of periprosthetic joint infection are C-reactive protein, leukocyte esterase, interleukin-6, interleukin-1β, α-defensin, and interleukin-17, all of which have high diagnostic utility.

Level Of Evidence: Level II.

Citing Articles

Simple and inexpensive synovial fluid biomarkers for the diagnosis of prosthetic joint infection according to the new EBJIS definition.

Diniz S, Ribau A, Vinha A, Oliveira J, Abreu M, Sousa R J Bone Jt Infect. 2023; 8(2):109-118.

PMID: 37032977 PMC: 10077577. DOI: 10.5194/jbji-8-109-2023.

Profiling the Immune Response to Periprosthetic Joint Infection and Non-Infectious Arthroplasty Failure.

Fisher C, Patel R Antibiotics (Basel). 2023; 12(2).

PMID: 36830206 PMC: 9951934. DOI: 10.3390/antibiotics12020296.

Serum versus synovial fluid interleukin-6 for periprosthetic joint infection diagnosis: a systematic review and meta-analysis of 30 diagnostic test accuracy studies.

Li J, Zhou Q, Deng B J Orthop Surg Res. 2022; 17(1):564.

PMID: 36566223 PMC: 9789601. DOI: 10.1186/s13018-022-03458-x.

Reimplantation after Periprosthetic Joint Infection: The Role of Microbiology.

Suardi V, Logoluso N, Anghilieri F, Santoro G, Pellegrini A Antibiotics (Basel). 2022; 11(10).

PMID: 36290065 PMC: 9598703. DOI: 10.3390/antibiotics11101408.

Role of serum and synovial procalcitonin in differentiating septic from non-septic arthritis- a prospective study.

Aggarwal P, Mahapatra S, Avasthi S, Aslam A, Kumar V J Clin Orthop Trauma. 2022; 31:101948.

PMID: 35865327 PMC: 9293762. DOI: 10.1016/j.jcot.2022.101948.